Novavax COVID jab shows high levels of protection against infection in two large phase-3 trials Ruchika Sharma18 Aug 2022 8:59 AM GMTDr Glenn further said the study was conducted with a vaccine based on the original Wuhan spike protein sequence.
Novavax tumbles 31 percent as waning COVID vaccine demand hits revenue forecast Ruchika Sharma12 Aug 2022 7:30 AM GMTBut only 7,381 Novavax vaccine doses have been administered so far in the country, with Chief Executive Stanley Erck saying that its late launch could...
Novavax COVID shot Nuvaxovid must carry warning of heart inflammation, recommends EU Ruchika Sharma4 Aug 2022 7:29 AM GMT"We will work with the relevant regulators to assure our product information is consistent with our common interpretation of the incoming data," U.S....
COVID vaccine: Novavax requests WHO to expand Emergency Use Listing of Nuvaxovid for adolescents aged 12 through 17 Ruchika Sharma1 Aug 2022 9:55 AM GMTThe WHO previously granted EUL for Nuvaxovid in adults aged 18 and older in December 2021.
Novavax, SK bioscience expand agreement to manufacture COVID vaccine containing Omicron variant Ruchika Sharma24 July 2022 5:30 AM GMTGaithersburg: Novavax, Inc has signed agreements with its partner, SK bioscience, for the manufacturing and supply of a version of the Novavax...
EU identifies severe allergic reactions as side effects of Novavax COVID vaccine Ruchika Sharma15 July 2022 11:00 AM GMTThe EMA said it would also update the product information for the vaccine to add unusual or decreased feeling in the skin as a new side effect.
Novavax COVID vaccine gets USFDA emergency use nod for 18 years and older Ruchika Sharma14 July 2022 6:44 AM GMTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19
Novavax COVID vaccine Nuvaxovid gets European Commission conditional nod for adolescents Ruchika Sharma6 July 2022 6:06 AM GMTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19
Novavax likely to come up with COVID vaccine targeting Omicron in Q4 Ruchika Sharma3 July 2022 7:00 AM GMTNew Delhi: Novavax Inc said on Friday it expects to provide a COVID-19 vaccine targeting Omicron in the fourth quarter as it accelerates development...
Novavax COVID vaccine Nuvaxovid recommended for expanded conditional marketing authorization in EU for adolescents Ruchika Sharma26 Jun 2022 7:00 AM GMTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19
Novavax COVID vaccine gets emergency use nod in Taiwan for adults Ruchika Sharma24 Jun 2022 6:03 AM GMTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19
Novavax COVID shot gets USFDA Advisory Committee recommendation for emergency use nod for 18 years and older Ruchika Sharma8 Jun 2022 6:44 AM GMTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19
